How Much Does Mounjaro Cost in Wisconsin in 2026?

Mounjaro Retail Price in Wisconsin

The manufacturer list price set by Eli Lilly for Mounjaro is $1,023 per month across all pen strengths, and Wisconsin retail pharmacies generally charge at or near that figure for cash-pay patients [1]. This price applies whether you fill at a chain pharmacy in Milwaukee, a regional independent in Madison, or a grocery-store pharmacy in Green Bay. Prices do not vary by dose tier because Eli Lilly uses a flat wholesale acquisition cost.

Why the Sticker Price Rarely Reflects What You Pay

Most Wisconsin residents do not pay full retail. Commercial insurance, Medicaid, Medicare Part D, manufacturer coupons, and compounded alternatives all reduce actual out-of-pocket spending. A 2023 IQVIA analysis estimated that roughly 80% of commercially insured GLP-1 fills involve some form of copay assistance or formulary discount [2]. The gap between list price and net price is wide, so the $1,023 figure is best understood as a ceiling, not a typical expense.

Cash-Pay Strategies at Wisconsin Pharmacies

If you have no insurance or your plan excludes GLP-1 medications, call multiple pharmacies before filling. Costco and independent pharmacies in Wisconsin sometimes price $20 to $60 below the list price for cash customers. Prescription discount aggregators (GoodRx, RxSaver) may show further variation, though discounts on brand Mounjaro remain modest compared to generic medications.

Compounded Tirzepatide in Wisconsin

Compounded tirzepatide is legally available in Wisconsin through 503A compounding pharmacies, and it costs approximately $249 per month [1]. That is roughly 75% less than brand-name Mounjaro. The price difference makes compounding the most accessible cash-pay option for many Wisconsin patients.

How 503A Compounding Works

A 503A pharmacy compounds medications on a patient-specific basis with a valid prescription. Under federal law (the Drug Quality and Security Act of 2013), 503A pharmacies may compound copies of FDA-approved drugs when certain conditions are met, including documented shortages or medical necessity [3]. Wisconsin's Pharmacy Examining Board licenses and inspects these facilities under state pharmacy law.

Safety Considerations

Compounded tirzepatide is not FDA-approved and does not undergo the same batch-level testing as Eli Lilly's product. The Endocrine Society has stated that "compounded peptides lack the rigorous quality controls of FDA-approved products, and patients should be counseled about these differences" [4]. If you choose a compounded product, verify that the pharmacy holds a current Wisconsin state license and follows USP 797 sterile compounding standards.

Brand vs. Compounded: Decision Checklist

Patients deciding between brand Mounjaro and compounded tirzepatide should weigh three factors: (1) insurance coverage status, because brand Mounjaro with a copay card may cost less than compounded product; (2) comfort with compounding pharmacy quality assurance; and (3) prescriber willingness, since some clinicians only prescribe FDA-approved formulations. Ask your provider which option fits your clinical and financial situation.

Wisconsin Medicaid Coverage for Mounjaro

Wisconsin Medicaid (BadgerCare Plus and fee-for-service) covers Mounjaro with prior authorization for adults with type 2 diabetes [1]. The prior authorization requires documentation of an A1C level, a trial of metformin (unless contraindicated), and a prescriber attestation that the patient meets diagnostic criteria. Coverage for weight management alone (off-label) is generally not approved under Wisconsin Medicaid.

Prior Authorization Steps

Your prescriber submits a PA request to the Wisconsin Department of Health Services or the managed care organization administering your plan. Typical turnaround is 3 to 5 business days. If denied, Wisconsin Medicaid allows a formal appeal. The denial letter includes instructions and deadlines. Gather lab results and office notes before the appeal to strengthen the case.

Medicaid Managed Care Plans

Most Wisconsin Medicaid enrollees receive benefits through a managed care organization such as Quartz, Molina, or UnitedHealthcare Community Plan. Formulary placement and PA criteria may vary slightly across these plans. Check your specific plan's drug list or call member services to confirm tirzepatide coverage before your prescriber writes the prescription.

Commercial Insurance Coverage in Wisconsin

Large commercial insurers operating in Wisconsin, including UnitedHealthcare, Anthem Blue Cross Blue Shield, Quartz, and Group Health Cooperative of South Central Wisconsin, increasingly cover Mounjaro on formulary for type 2 diabetes. Coverage for obesity (off-label for Mounjaro, on-label for Zepbound) depends on the employer's benefit design.

Formulary Tiers and Copays

Mounjaro typically sits on a specialty or non-preferred brand tier, which means higher copays ($50 to $150 per fill) before any manufacturer assistance. Some self-insured employer plans in Wisconsin have moved tirzepatide to preferred brand status, dropping copays to $25 to $50. Your plan's Summary of Benefits and Coverage document lists the exact tier.

Step Therapy Requirements

Several Wisconsin insurers require step therapy: you must try and fail metformin (and sometimes a sulfonylurea or SGLT2 inhibitor) before the plan approves Mounjaro. In the SURPASS-2 trial (N=1,879), tirzepatide 15 mg reduced A1C by 2.58% from baseline compared with 1.86% for semaglutide 1 mg over 40 weeks [5]. That level of glycemic efficacy is why many clinicians push back on step therapy denials for patients with A1C above 8%.

The Eli Lilly Savings Card

Eli Lilly offers a manufacturer savings card that reduces copays for commercially insured patients. Eligible patients may pay as little as $25 per monthly fill, with Lilly covering the remainder up to a set annual cap [6]. The card is not valid for patients using government insurance (Medicare, Medicaid, Tricare, VA).

Eligibility and Enrollment

To qualify, you need a valid Mounjaro prescription, commercial insurance that covers tirzepatide, and U.S. Residency. Enrollment happens online through Lilly's patient portal or by phone. The card activates immediately and can be used at any Wisconsin pharmacy that accepts manufacturer copay cards. Most chain pharmacies process the card at the point of sale.

What Happens When the Card Expires

Savings cards typically reset on a calendar-year basis. If Lilly discontinues the program or changes terms, your out-of-pocket cost reverts to whatever your insurance copay or coinsurance dictates. Monitor Lilly's website for annual updates. Patients who rely on the card should budget for the possibility that terms may shift.

Telehealth Prescribing of Mounjaro in Wisconsin

Wisconsin allows telehealth prescribing of Mounjaro. A licensed prescriber can evaluate you via video visit, order labs, and send a prescription to your preferred Wisconsin pharmacy [1]. This is especially useful for patients in rural parts of the state where endocrinology or obesity medicine specialists are scarce.

How a Telehealth Visit Works

You schedule a video appointment with a provider licensed in Wisconsin. The clinician reviews your medical history, current medications, and lab work (A1C, kidney function, lipid panel). If tirzepatide is appropriate, the prescription is sent electronically. Some telehealth platforms also coordinate with compounding pharmacies for direct-to-patient shipping.

Wisconsin Telehealth Regulations

Wisconsin Statute 448.015 defines telehealth broadly and does not require an in-person visit before prescribing. The Ryan Haight Act applies to controlled substances but does not restrict GLP-1 receptor agonists, which are not scheduled drugs [7]. Your telehealth provider must hold an active Wisconsin medical license.

Clinical Efficacy: What You Get for the Cost

Mounjaro's price reflects a dual-action mechanism. Tirzepatide activates both GIP and GLP-1 receptors, a pharmacologic approach distinct from semaglutide's GLP-1-only mechanism [5]. The clinical data supporting this dual agonism is substantial.

Weight Loss Outcomes

In the SURMOUNT-1 trial (N=2,539), tirzepatide 15 mg produced 22.5% mean body weight reduction at 72 weeks versus 2.4% with placebo [8]. That translates to roughly 52 pounds lost for a participant starting at 231 pounds. Dr. Ania Jastreboff, the trial's lead investigator at Yale, described the results as "a magnitude of weight reduction not previously seen with a single pharmacotherapy in a randomized trial" [8].

Glycemic Control

SURPASS-2 demonstrated that tirzepatide 15 mg achieved A1C reductions of 2.58 percentage points versus 1.86 for semaglutide 1 mg (P<0.001), with 92% of tirzepatide patients reaching an A1C below 7% [5]. For Wisconsin patients whose insurers require evidence of superiority to approve a non-preferred agent, these head-to-head data against semaglutide provide strong clinical justification.

Cardiovascular Signal

The SELECT-T2D sub-analysis and the ongoing SURPASS-CVOT trial are evaluating tirzepatide's cardiovascular outcomes. Preliminary data from SURPASS-4 showed no increase in major adverse cardiovascular events over 104 weeks of treatment [9]. Full CVOT results are expected to further clarify tirzepatide's long-term safety profile.

How to Minimize Your Mounjaro Cost in Wisconsin

The lowest price depends on your coverage situation. Here is a straightforward breakdown by scenario.

If You Have Commercial Insurance

Apply for the Eli Lilly savings card first. If your plan covers Mounjaro, the combination of insurance plus the card often brings monthly cost below $50. If your plan excludes GLP-1 drugs, the savings card will not help, and you should explore compounded tirzepatide or ask your employer's benefits team to add coverage.

If You Have Wisconsin Medicaid

Request prior authorization through your managed care plan. If approved, your copay is minimal (often $0 to $3). Keep lab work current because PA renewals require updated A1C values, typically every 6 to 12 months.

If You Have Medicare

Medicare Part D covers Mounjaro for type 2 diabetes, but coverage varies by plan. The Lilly savings card is not valid for Medicare beneficiaries. Check your plan's formulary and contact Medicare's helpline (1-800-MEDICARE) for plan comparison. The Inflation Reduction Act's $2,000 annual out-of-pocket cap on Part D spending (effective 2025) limits maximum exposure [10].

If You Are Uninsured

Compounded tirzepatide at roughly $249 per month is the most cost-effective path. Lilly's patient assistance program (Lilly Cares) also provides brand Mounjaro at no cost to qualifying uninsured patients with household income at or below 400% of the federal poverty level [6].

Comparing Wisconsin Mounjaro Costs to Neighboring States

Wisconsin's Mounjaro pricing is consistent with the broader Midwest. The Eli Lilly list price is identical nationwide. Compounded tirzepatide prices vary by pharmacy but cluster between $200 and $350 per month across Wisconsin, Minnesota, Illinois, Iowa, and Michigan. Medicaid coverage differs: Illinois covers Mounjaro with PA similar to Wisconsin, while Iowa's Medicaid program has a more restrictive preferred drug list that may require additional documentation.